What are the responsibilities of a clinical trial sponsor?
The clinical trial sponsor is the entity responsible for initiating, organizing, financing, and overseeing a clinical trial. The sponsor bears ultimate responsibility for ensuring that the trial complies with applicable laws, Good Clinical Practice (ICH GCP) principles, and the approved study protocol.
One of the sponsor’s primary responsibilities is planning the clinical trial. This includes preparing the study protocol, Investigator’s Brochure, Informed Consent Form (ICF), documents for the Ethics Committee and regulatory authorities, as well as other documentation required to initiate the project. The sponsor is also responsible for properly submitting the trial to the relevant authorities, including, in the case of clinical trials of medicinal products conducted in the European Union, submitting the application through the CTIS system.
The sponsor is also responsible for selecting appropriate study sites and investigators with the experience and qualifications required to conduct the trial. The sponsor enters into agreements with study sites, provides project funding, and arranges the supply of the investigational medicinal product or medical device, where required.
A key responsibility of the sponsor is ensuring participant safety. The sponsor is responsible for implementing a safety monitoring system, assessing reported adverse events, and ensuring the timely reporting of serious and unexpected adverse reactions to the relevant regulatory authorities and Ethics Committee in accordance with applicable regulations.
The sponsor must also ensure the quality of the data collected during the trial. In practice, this involves implementing a quality management system, monitoring trial conduct, managing risks, and overseeing the completeness and reliability of study documentation. Increasingly, these activities are carried out in accordance with Risk-Based Quality Management principles, which help focus oversight on processes with the greatest impact on participant safety and the reliability of study results.
Another important responsibility is maintaining trial documentation, including the Trial Master File (TMF), which contains key documents related to the planning, conduct, and completion of the project. The documentation must be complete, up to date, and readily available for audits and inspections conducted by regulatory authorities.
After the trial is completed, the sponsor is responsible for analyzing the results, preparing the final report, and fulfilling obligations related to the publication and reporting of trial results in the relevant registries. Depending on the type of study, regulations may also require participants to be provided with information about the results of the project.
Proper fulfillment of the sponsor’s responsibilities is essential to the success of the entire project. Effective trial oversight, quality management, and compliance with regulatory requirements not only increase the credibility of the results but, above all, ensure the protection of the rights, safety, and well-being of clinical trial participants.
